The National Agency for Food and Drug Administration and Control has announced the approval for the use of Johnson and Johnson COVID-19 vaccine in Nigeria.
The Director-General of NAFDAC, Mojisola Adeyeye , made the announcement in a statement on Tuesday.
In a statement signed by the agency’s spokesperson, Dr Abubakar Jimoh, titled “NAFDAC grants emergency use authorisation for the ‘johnson and johnson’ vaccine, the NAFDAC DG said the vaccine is for emergency use.
It read: “NAFDAC is hereby granting conditional emergency use authorisation for Janssen Covid-19 vaccine to prevent COVID’19 in people from 18 years of age
“After a thorough evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety, and quality ”
The approval brings to three the number of COVID-19 vaccines approved for use in Nigeria by the agency — after AstraZeneca and Pfizer were authorised in February and April respectively.
